← Back to front page
United States · Financial press · Investor's Business Daily

CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out

Published by Investor's Business Daily · United States 32 min ago
CG Oncology Exceeds Even The 'Most Bullish Conversations;' Shares Break Out
Investor's Business Daily

Detailed summary

CG Oncology said Monday its experimental bladder cancer treatment cut the risk of recurrence by 68%. The biotech stock broke out. The post CG Oncology Exceeds Even The 'Most…

CG Oncology (CGON) said Monday its experimental bladder cancer treatment cut the risk of recurrence by 68%. The news sent the biotech stock flying into breakout territory. "We see these results as meaningfully exceeding both the powering expectations (~30%) and investor expectations (~40%), and even in our most bullish conversations we did not hear investors expect a risk reduction greater…

Opening of the article, excerpted from Investor's Business Daily. To read the rest, open the article on the publisher's site.

Read the full article on Investor's Business Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)

Also worth reading